Overview
TranSVIR is an FP7 EU funded Marie Curie Initial Training Network (ITN) with four Academic Partners (MUW, University of Cambridge, Leiden University Medical Centre and Trinity College Dublin) and two Industry Partners (AstraZeneca, UK, and Hycult Biotech, The Netherlands). It will provide multidisciplinary research training in the basic immune and cell biological mechanisms responsible for vascular inflammation and repair together with the complementary skills required to translate this basic knowledge into the clinic. The present post is one of two to be based in the Cambridge Institute for Medical Research and supervised by Professor KGC Smith ( http://www.cimr.cam.ac.uk/investigators/smith/profile.php ). The person appointed will be trained in high throughput genomic and cellular immunological techniques together with complementary training in translational science both from an academic and an Industry perspective. The TranSVIR ITN is highly integrated and so the appointee will also have the opportunity to acquire additional skills through regular TranSVIR meetings and through attachments to other laboratories in the TranSVIR network.
The project, entitled "Predicting response in inflammatory vascular disease", is an extension of ongoing work in our laboratory that has recently led to the identification of a gene expression based biomarker that predicts outcome in two autoimmune diseases (McKinney et al Nature Medicine 16:586-91, 2010). The broad aim of this project will be to gain insight into the underlying genetic and epigenomic processes that direct this transcriptional programme and how ultimately this drives the disease process. In addition, the current biomarker will be further refined and optimised to develop an assay more suited for use in a clinical setting.
Funding
TranSVIR is funded under the Marie Curie Mobility Program designed to promote movement of researchers in Europe and so is open to citizens from any country in the world other than the UK provided they have not worked there for more than 12 months in the previous three years. However, UK citizens are also eligible if they have not worked in the UK for more than 12 months. TranSVIR pursues a policy of equal opportunities on matters of gender and disability and will seek to recruit an equal proportion of male and female applicants and will provide employment opportunities for candidates with disabilities. Where applications of equal quality are received, preference will be given to female candidates as part of a strategy designed to recruit equal numbers of men and women to the TranSVIR posts. Employment procedures and contracts will conform to the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The stipend and allowances are determined in accordance with the terms of an EU FP7 Marie Curie ITN and are in the region of 40k euros per annum.
Enquiries
For informal enquiries please contact Dr Paul Lyons (pal34@cam.ac.uk). To apply send CV, completed CHRIS6 (http://www.admin.cam.ac.uk/offices/hr/forms/chris6 ), copies of relevant certificates and 2 letters of recommendation to Dr Paul Lyons (pal34@cam.ac.uk ) , Cambridge Institute for Medical Research, Department of Medicine, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY.
Please kindly mention Scholarization.blogspot.com when applying for this opportunity
TranSVIR is an FP7 EU funded Marie Curie Initial Training Network (ITN) with four Academic Partners (MUW, University of Cambridge, Leiden University Medical Centre and Trinity College Dublin) and two Industry Partners (AstraZeneca, UK, and Hycult Biotech, The Netherlands). It will provide multidisciplinary research training in the basic immune and cell biological mechanisms responsible for vascular inflammation and repair together with the complementary skills required to translate this basic knowledge into the clinic. The present post is one of two to be based in the Cambridge Institute for Medical Research and supervised by Professor KGC Smith ( http://www.cimr.cam.ac.uk/investigators/smith/profile.php ). The person appointed will be trained in high throughput genomic and cellular immunological techniques together with complementary training in translational science both from an academic and an Industry perspective. The TranSVIR ITN is highly integrated and so the appointee will also have the opportunity to acquire additional skills through regular TranSVIR meetings and through attachments to other laboratories in the TranSVIR network.
The project, entitled "Predicting response in inflammatory vascular disease", is an extension of ongoing work in our laboratory that has recently led to the identification of a gene expression based biomarker that predicts outcome in two autoimmune diseases (McKinney et al Nature Medicine 16:586-91, 2010). The broad aim of this project will be to gain insight into the underlying genetic and epigenomic processes that direct this transcriptional programme and how ultimately this drives the disease process. In addition, the current biomarker will be further refined and optimised to develop an assay more suited for use in a clinical setting.
Funding
TranSVIR is funded under the Marie Curie Mobility Program designed to promote movement of researchers in Europe and so is open to citizens from any country in the world other than the UK provided they have not worked there for more than 12 months in the previous three years. However, UK citizens are also eligible if they have not worked in the UK for more than 12 months. TranSVIR pursues a policy of equal opportunities on matters of gender and disability and will seek to recruit an equal proportion of male and female applicants and will provide employment opportunities for candidates with disabilities. Where applications of equal quality are received, preference will be given to female candidates as part of a strategy designed to recruit equal numbers of men and women to the TranSVIR posts. Employment procedures and contracts will conform to the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The stipend and allowances are determined in accordance with the terms of an EU FP7 Marie Curie ITN and are in the region of 40k euros per annum.
Enquiries
For informal enquiries please contact Dr Paul Lyons (pal34@cam.ac.uk). To apply send CV, completed CHRIS6 (http://www.admin.cam.ac.uk/offices/hr/forms/chris6 ), copies of relevant certificates and 2 letters of recommendation to Dr Paul Lyons (pal34@cam.ac.uk ) , Cambridge Institute for Medical Research, Department of Medicine, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY.
Please kindly mention Scholarization.blogspot.com when applying for this opportunity
0 comments:
Post a Comment